0001193125-23-139499.txt : 20230509 0001193125-23-139499.hdr.sgml : 20230509 20230509165633 ACCESSION NUMBER: 0001193125-23-139499 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20230509 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230509 DATE AS OF CHANGE: 20230509 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MICROVISION, INC. CENTRAL INDEX KEY: 0000065770 STANDARD INDUSTRIAL CLASSIFICATION: ELECTRONIC COMPONENTS, NEC [3679] IRS NUMBER: 911600822 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34170 FILM NUMBER: 23903063 BUSINESS ADDRESS: STREET 1: 18390 NE 68TH STREET CITY: REDMOND STATE: WA ZIP: 98052 BUSINESS PHONE: 425-936-6847 MAIL ADDRESS: STREET 1: 18390 NE 68TH STREET CITY: REDMOND STATE: WA ZIP: 98052 FORMER COMPANY: FORMER CONFORMED NAME: MICROVISION INC DATE OF NAME CHANGE: 19960724 8-K 1 d500868d8k.htm 8-K 8-K
false 0000065770 0000065770 2023-05-09 2023-05-09

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED) May 9, 2023

 

 

MicroVision, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-34170   91-1600822

(State or other jurisdiction

of incorporation)

  

(Commission

File Number)

  

(I.R.S. Employer

Identification No.)

18390 NE 68th Street

Redmond, Washington 98052

(Address of principal executive offices) (Zip code)

(425) 936-6847

Registrant’s telephone number, including area code

Not Applicable

(Former name or former address if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  ☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  ☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  ☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  ☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

  

Trading

symbol(s)

  

Name of each exchange

on which registered

Common stock, par value $0.001 per share   MVIS   The NASDAQ Stock Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 2.02. Results of Operations and Financial Condition.

The information in this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.

On May 9, 2023, MicroVision, Inc. issued a press release announcing its first quarter 2023 results. A copy of the press release is attached as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(c) Exhibits.

Pursuant to the rules and regulations of the SEC, the attached exhibit is deemed to have been furnished to, but not filed with, the SEC.

 

Exhibit No.

   

Description

99.1    Press Release of MicroVision, Inc. dated May 9, 2023
104    Cover Page Interactive File (the cover page tags are embedded within the Inline XBRL document)

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

MICROVISION, INC.
By:    

/s/ Drew G. Markham

  Drew G. Markham
  Vice President, General Counsel and Secretary

Dated: May 9, 2023

EX-99.1 2 d500868dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

 

LOGO

MicroVision Announces First Quarter 2023 Results

REDMOND, WA / ACCESSWIRE / May 9, 2023 / MicroVision, Inc. (NASDAQ:MVIS), a leader in MEMS-based solid-state automotive lidar and ADAS solutions, today announced its first quarter 2023 results.

“Following the closing in January of our acquisition of assets from Ibeo Automotive Systems GmbH, we are energized by the strength of our combined team, accelerated engagement with multiple OEMs, and positive financial performance in Q1 2023. Revenue of $0.8 million was ahead of our expectations, primarily driven by the acquisition.” said Sumit Sharma, MicroVision’s Chief Executive Officer. “I am pleased with our significant achievements in the first quarter, with the momentum in our top line driven by our expanded product offerings and the efficient integration of our U.S. and Germany teams.

“With the dynamic-view MAVIN™, our MEMS-based scanning lidar for long-range highway pilot; MOVIA™, our flash-based short-range lidar for automotive and non-automotive applications; and MOSAIK™, our validation software suite for OEMs and Tier 1s, MicroVision is uniquely positioned to capture meaningful market share in both automotive and non-automotive verticals,” continued Sharma. “Our product offerings and unmatched technical capabilities are proving to be compelling in key RFIs and RFQs from several OEMs around the globe. We maintain our 2023 revenue guidance of $10-15 million from our expanded product suite.”

Key Financial Highlights for Q1 2023

 

  •  

Revenue for the first quarter of 2023 was $0.8 million, compared to $0.4 million for the first quarter of 2022. The revenue growth in the first quarter was primarily due to the Ibeo acquisition and includes the sale of lidar hardware and related software to various customers.

 

  •  

Net loss for the first quarter of 2023 was $19.0 million, or $0.11 per share, which includes $2.9 million of non-cash, share-based compensation expense, $1.7 million bargain purchase price gain and $0.3 million of non-cash amortization of intangibles, compared to a net loss for the first quarter of 2022 of $13.2 million, or $0.08 per share, which includes $3.7 million of non-cash, share-based compensation expense.

 

  •  

Adjusted Gross Profit for the first quarter of 2023 was a $0.5 million, compared to a $0.3 million for the first quarter of 2022.

 

  •  

Adjusted EBITDA for the first quarter of 2023 was a $15.8 million loss, compared to a $9.0 million loss for the first quarter of 2022.

 

  •  

Cash used in operations in the first quarter of 2023 was $13.8 million, compared to cash used in operations in the first quarter of 2022 of $10.9 million.

 

  •  

The Company ended the first quarter of 2023 with $67.7 million in cash and cash equivalents including investment securities, compared to $82.7 million at December 31, 2022.

Conference Call and Webcast: Q1 2023 Results

MicroVision will host a conference call and webcast, consisting of prepared remarks by management, a slide presentation, and a question-and-answer session at 2:00 PM PT/5:00 PM ET on Tuesday, May 9, 2023 to discuss the financial results and provide a business update. Analysts and investors may pose questions to management during the live webcast on May 9, 2023.

The live webcast and slide presentation can be accessed on the Company’s Investor Relations website under the Events tab at https://ir.microvision.com/events. The webcast will be archived on the website for future viewing.

About MicroVision

With over 350 employees and global presence in Redmond, Detroit, Hamburg, and Nuremberg, MicroVision is a pioneering company in MEMS-based laser beam scanning technology that integrates MEMS, lasers, optics, hardware, algorithms and machine learning software into its proprietary technology to address existing and emerging markets. The Company’s integrated approach uses its proprietary technology to provide automotive lidar sensors and solutions for advanced driver-assistance systems (ADAS) and for non-automotive applications including industrial, smart infrastructure and robotics. The Company has been leveraging its experience building augmented reality micro-display engines, interactive display modules, and consumer lidar modules.

For more information, visit the Company’s website at www.microvision.com, on Facebook at www.facebook.com/microvisioninc, and LinkedIn at https://www.linkedin.com/company/microvision/.

MicroVision, MAVIN, MOSAIK, and MOVIA are trademarks of MicroVision, Inc. in the United States and other countries. All other trademarks are the properties of their respective owners.

Non-GAAP information

To supplement MicroVision’s condensed financial statements presented in accordance with GAAP, the Company presents investors with the non-GAAP financial measure “adjusted EBITDA” and “adjusted Gross Profit.” Adjusted EBITDA consists of GAAP net income (loss) excluding the impact of the following: interest income and interest expense; income tax expense; depreciation and amortization; and share-based compensation. Adjusted Gross Profit is calculated as GAAP gross profit before stock-based compensation expense and the amortization of acquired intangibles included in cost of revenue.

MicroVision believes that the presentation of adjusted EBITDA and adjusted Gross Profit provides important supplemental information to management and investors regarding financial and business trends, provides consistency and comparability with MicroVision’s past financial reports, and facilitates comparisons with other companies in the Company’s industry, many of which use similar non-GAAP financial measures to supplement their GAAP results. Internally, management uses this non-GAAP measure when evaluating operating performance because the exclusion of the items described above provides an additional useful measure of the Company’s operating results and facilitates comparisons of the Company’s core operating performance against prior periods and its business objectives. Externally, the Company believes that adjusted EBITDA and adjusted Gross Profit is useful to investors in their assessment of MicroVision’s operating performance and the valuation of the Company.

Adjusted EBITDA and adjusted Gross Profit is not calculated in accordance with GAAP, and should be considered supplemental to, and not as a substitute for, or superior to, financial measures calculated in accordance with GAAP. Non-GAAP financial measures have limitations in that they do not reflect all of the costs associated with the operations of MicroVision’s business as determined in accordance with

GAAP. The Company expects to continue to incur expenses similar to the non-GAAP adjustments described above, and exclusion of these items from its non-GAAP financial measure should not be construed as an inference that these costs are unusual or infrequent. The Company compensates for limitations of the measure by prominently disclosing GAAP net income (loss), which the Company believes is the most directly comparable GAAP measure, and providing investors with a reconciliation from GAAP net income (loss) to adjusted EBITDA.

Similarly for Adjusted Gross Profit, the Company compensates for limitations of the measure by prominently disclosing GAAP gross profits which is the difference between Revenue and Cost of revenue, which the Company believes is the most directly comparable GAAP measure, and providing investors with a reconciliation by backing out stock-based compensation expense and the amortization of acquired intangibles included in cost of revenue.

Forward-Looking Statements

Certain statements contained in this release, including the Company’s plans regarding benefits of the acquisition, market position, product portfolio, product capabilities, and expected revenue, expenses and cash usage are forward-looking statements that involve a number of risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those projected in such forward-looking statements include the risk its ability to operate with limited cash or to raise additional capital when needed; market acceptance of its technologies and products or for products incorporating its technologies; the failure of its commercial partners to perform as expected under its agreements, including from the impact of COVID-19 (coronavirus); its financial and technical resources relative to those of its competitors; its ability to keep up with rapid technological change; government regulation of its technologies; its ability to enforce its intellectual property rights and protect its proprietary technologies; the ability to obtain customers and develop partnership opportunities; the timing of commercial product launches and delays in product development; the ability to achieve key technical milestones in key products; dependence on third parties to develop, manufacture, sell and market its products; potential product liability claims; its ability to maintain its listing on The Nasdaq Stock Market, and other risk factors identified from time to time in the Company’s SEC reports, including the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other reports filed with the SEC. These factors are not intended to represent a complete list of the general or specific factors that may affect the Company. It should be recognized that other factors, including general economic factors and business strategies, may be significant, now or in the future, and the factors set forth in this release may affect the Company to a greater extent than indicated. Except as expressly required by federal securities laws, the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changes in circumstances or any other reason.

Investor Relations Contact

Jeff Christensen

Darrow Associates Investor Relations

MVIS@darrowir.com

Media Contact

Robyn Komachi

Marketing@MicroVision.com

Source: MicroVision, Inc.

MicroVision, Inc.

Consolidated Balance Sheet

(In thousands)

(Unaudited)

 

     March 31,      December 31,  
     2023      2022  

Assets

      

Current Assets

      

Cash and cash equivalents

    $ 23,187      $ 20,536  

Investment securities, available-for-sale

      44,544        62,173  

Restricted cash, current

      3,263        —    

Accounts receivable, net

      506        —    

Contract assets

      192        —    

Inventory

      3,116        1,861  

Advance to IBEO

      —          4,132  

Other current assets

      2,182        2,306  
  

 

 

     

 

 

  

Total current assets

      76,990        91,008  

Property and equipment, net

      10,284        6,830  

Operating lease right-of-use asset

      14,746        14,579  

Restricted cash

      961        1,418  

Intangible assets, net

      19,000        75  

Other assets

      1,281        1,086  
  

 

 

     

 

 

  

Total assets

    $ 123,262      $ 114,996  
  

 

 

     

 

 

  

Liabilities and Shareholders’ Equity

      

Current Liabilities

      

Accounts payable

    $ 3,629      $ 2,061  

Accrued liabilities

      10,414        2,058  

Contract liabilities

      5,676        4,601  

Other current liabilities

      211        839  

Current portion of operating lease liability

      2,210        1,846  

Current portion of finance lease obligations

      15        21  
  

 

 

     

 

 

  

Total current liabilities

      22,155        11,426  

Operating lease liability, net of current portion

      13,729        13,829  

Deferred tax liabilities

      823        —    

Other long-term liabilities

      17        —    
  

 

 

     

 

 

  

Total liabilities

      36,724        25,255  
  

 

 

     

 

 

  

Commitments and contingencies

      

Shareholders’ Equity

      

Common stock at par value

      176        171  

Additional paid-in capital

      787,856        772,221  

Accumulated other comprehensive loss

      57        (127 ) 

Accumulated deficit

      (701,551 )       (682,524 ) 
  

 

 

     

 

 

  

Total shareholders’ equity

      86,538        89,741  
  

 

 

     

 

 

  

Total liabilities and shareholders’ equity

    $ 123,262      $ 114,996  
  

 

 

     

 

 

  

MicroVision, Inc.

Consolidated Statement of Operations

(In thousands, except earnings per share data)

(Unaudited)

 

     Three months ended March 31,  
     2023      2022  

Revenue

    $ 782      $ 350  

Cost of revenue

      544        4  
  

 

 

     

 

 

  

Gross profit

      238        346  
  

 

 

     

 

 

  

Research and development expense

      12,692        7,593  

Sales, marketing, general and administrative expense

      8,737        5,877  
  

 

 

     

 

 

  

Total operating expenses

      21,429        13,470  
  

 

 

     

 

 

  

Loss from operations

      (21,191 )       (13,124 ) 

Bargain purchase gain, net of tax

      1,706        —    

Other income (expense), net

      639        (44 ) 
  

 

 

     

 

 

  

Net loss before taxes

    $ (18,846 )     $ (13,168 ) 

Income tax expense

      (181 )       —    
  

 

 

     

 

 

  

Net income (loss)

    $ (19,027 )     $ (13,168 ) 
  

 

 

     

 

 

  

Net income (loss) per share - basic and diluted

    $ (0.11 )     $ (0.08 ) 
  

 

 

     

 

 

  

Weighted-average shares outstanding - basic and diluted

      174,703        164,563  
  

 

 

     

 

 

  

MicroVision, Inc.

Consolidated Statement of Cash Flows

(In thousands)

(Unaudited)

 

     Three months ended March 31,  
     2023      2022  

Cash flows from operating activities

      

Net loss

    $ (19,027 )     $ (13,168 ) 

Adjustments to reconcile net loss to net cash used in operations:

      

Depreciation and amortization

      2,271        483  

Bargain purchase gain, net of tax

      1,706        —    

Impairment of property and equipment

      —          60  

Share-based compensation expense

      2,949        3,734  

Inventory write-downs

      29        —    

Net accretion of premium on short-term investments

      (396 )       160  

Change in

      

Accounts receivable

      (506 )       —    

Contract assets

      (192 )       —    

Inventory

      (87 )       (35 ) 

Other current and non-current assets

      647        389  

Accounts payable

      1,629        (1,292 ) 

Accrued liabilities

      (2,367 )       118  

Contract liabilities and other current liabilities

      195        (1,057 ) 

Operating lease liabilities

      (669 )       (299 ) 

Other clong-term liabilities

      17        —    
  

 

 

     

 

 

  

Net cash used in operating activities

      (13,801 )       (10,907 ) 
  

 

 

     

 

 

  

Cash flows from investing activities

      

Sales of investment securities

      22,000        1,500  

Purchases of investment securities

      (3,898 )       (16,696 ) 

Acquisition of Ibeo assets

      (10,914 )       —    

Purchases of property and equipment

      (615 )       (884 ) 
  

 

 

     

 

 

  

Net cash provided by (used in) investing activities

      6,573        (16,080 ) 
  

 

 

     

 

 

  

Cash flows from financing activities

      

Principal payments under finance leases

      (6 )       (8 ) 

Principal payments under long-term debt

      —          (294 ) 

Proceeds from stock option exercises

      —          253  

Net proceeds from issuance of common stock

      12,691        —    
  

 

 

     

 

 

  

Net cash provided by financing activities

      12,685        (49 ) 
  

 

 

     

 

 

  

Change in cash, cash equivalents, and restricted cash

      5,457        (27,036 ) 

Cash, cash equivalents and restricted cash at beginning of period

      21,954        83,739  
  

 

 

     

 

 

  

Cash, cash equivalents and restricted cash at end of period

    $ 27,411      $ 56,703  
  

 

 

     

 

 

  

MicroVision, Inc.

Reconciliation of GAAP to Non-GAAP Measures

(In thousands, except earnings per share data)

(Unaudited)

 

     Three months ended March 31,  
     2023      2022  

Reconciliation of Non-GAAP Gross Profit:

      

Gross Profit

    $ 238      $ 346  

Share-based compensation expense

      —          —    

Amortization of acquired intangibles

      255        —    
  

 

 

     

 

 

  

Non-GAAP Gross Profit

    $ 493      $ 346  
  

 

 

     

 

 

  

Reconciliation of GAAP Net Loss to Non-GAAP Measure:

      

GAAP net loss

    $ (19,027 )     $ (13,168 ) 

Add Interest (net)

      (499 )       (31 ) 

Add Income taxes

      181        —    

Add Bargain gurchase gain

      (1,706 )    

Add Depreciation & amorization

      2,271        483  

Add Share-based compensation expense

      2,949        3,734  
  

 

 

     

 

 

  

Adjusted EBITDA

    $ (15,831 )     $ (8,982 ) 
  

 

 

     

 

 

  
 EX-101.SCH 3 mvis-20230509.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 4 mvis-20230509_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company EX-101.PRE 5 mvis-20230509_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 6 g500868snap11.jpg GRAPHIC begin 644 g500868snap11.jpg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htm IDEA: XBRL DOCUMENT v3.23.1
Document and Entity Information
May 09, 2023
Cover [Abstract]  
Amendment Flag false
Entity Central Index Key 0000065770
Document Type 8-K
Document Period End Date May 09, 2023
Entity Registrant Name MicroVision, Inc.
Entity Incorporation State Country Code DE
Entity File Number 001-34170
Entity Tax Identification Number 91-1600822
Entity Address, Address Line One 18390 NE 68th Street
Entity Address, City or Town Redmond
Entity Address, State or Province WA
Entity Address, Postal Zip Code 98052
City Area Code (425)
Local Phone Number 936-6847
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common stock, par value $0.001 per share
Trading Symbol MVIS
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 8 d500868d8k_htm.xml IDEA: XBRL DOCUMENT 0000065770 2023-05-09 2023-05-09 false 0000065770 8-K 2023-05-09 MicroVision, Inc. DE 001-34170 91-1600822 18390 NE 68th Street Redmond WA 98052 (425) 936-6847 false false false false Common stock, par value $0.001 per share MVIS NASDAQ false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 1 22 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://microvision.com//20230509/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d500868d8k.htm d500868dex991.htm mvis-20230509.xsd mvis-20230509_lab.xml mvis-20230509_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d500868d8k.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 22 }, "contextCount": 1, "dts": { "inline": { "local": [ "d500868d8k.htm" ] }, "labelLink": { "local": [ "mvis-20230509_lab.xml" ] }, "presentationLink": { "local": [ "mvis-20230509_pre.xml" ] }, "schema": { "local": [ "mvis-20230509.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 0, "nsprefix": "mvis", "nsuri": "http://microvision.com/20230509", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "div", "div", "body", "html" ], "baseRef": "d500868d8k.htm", "contextRef": "duration_2023-05-09_to_2023-05-09", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "menuCat": "Cover", "order": "1", "role": "http://microvision.com//20230509/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "div", "div", "body", "html" ], "baseRef": "d500868d8k.htm", "contextRef": "duration_2023-05-09_to_2023-05-09", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://microvision.com//20230509/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://microvision.com//20230509/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://microvision.com//20230509/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://microvision.com//20230509/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://microvision.com//20230509/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://microvision.com//20230509/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://microvision.com//20230509/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://microvision.com//20230509/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://microvision.com//20230509/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://microvision.com//20230509/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://microvision.com//20230509/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://microvision.com//20230509/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://microvision.com//20230509/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://microvision.com//20230509/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://microvision.com//20230509/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://microvision.com//20230509/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://microvision.com//20230509/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://microvision.com//20230509/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://microvision.com//20230509/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://microvision.com//20230509/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://microvision.com//20230509/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://microvision.com//20230509/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 15 0001193125-23-139499-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-23-139499-xbrl.zip M4$L#!!0 ( !"'J58BNXSC @\ /!= . 9#4P,#@V.&0X:RYH=&WM M7&USXK86_MZ9_@<->[>3S 2P@21 7NZDA-TRW9!<8+>=^Z4C;!'4-98KR0G< M7W_/D6TP[Y"0L-UF9]I@2SXZ.GK.JV2?_WLX\,@#DXH+_R)CYZP,8;XC7.[? M7V1"WA0P->[=HZJ;$_(^G[1,=?>%[X>#<>?'Q\><(8\/N%KF\8D\=,I" M+R:YDSPW]+C_=>JQQZ)YR*Y4*GG3FG2=ZSD>H&!9Q3PV=ZEB2??! Y\P/^". M%' #))5SQ !9+UK'5F7,AN*+F #"=O[WFT]MI\\&-,M]I:GOC(<(M5S*4"4/ MK4E'KD2I8)^NX#[N,7Y@N*RO#7U]F"O[_>?6ITEWO;C_I&M>2^JKGI #JD$* M2.DX:Q6RA9,4D2R@88I0@HYU=,K9HCV6)0S.5TUU1HK8ZLZ@,NY\DH\:XZ[+ M<8((SQBH,^KB7\VUQR[+V5_/\]%/N#=@FA*DD&5_A?SA(E,3OF:^SG8 G!GB M1%<7&A\S,=0MUH/F4!H9_X%H MS5H@YLH?6J2N,I<]ZBEVGI\B/C<8=R\ROQ@^_H 1_ZC[()%1#8:4U&OX+AO^ MRD:9%$M+.FS)FH7_3HY/3ZUY_O(SDI&LQR38+J;@&A6YJHS&P5C$V( JVH^+ MC.*#P$/@F'M]B:R@GF<3?9Z?GD\\^ZD9FVLE M0AE=&@6JQN(VJ[>!N)/'F%F\\25W\4:/,TD,"VRA>M<:OTXOV.S#R/5"^@&L MJ'#'EZ#94E]3S2XGO"5/3MHFO+I+^B8MXV''X^2GI#.6YD1Z^;0&YD%3X4]* M7_&I+/7XO5]U8"Y,9J;;'[FK^]5R[IC[9ZF^'NOILP&5]]S/XN\JH:$6R1W) M[_OQ+207),30:&;[S+2"?P[&)+0(JJG+KM!:#,R=KI# >G+'#H9$"8^[Y)U9 M'BMS^=,[^\0Z.\\'RP8JKA^H\.2!4F21")F? .G!TF05_Q^KVN7Q=8\.N#>J M=OB *=)DCZ0E!M0_,VV/$=]=X;EG"Y;G<[/1J5^3=N>J4V\O9\=Z)7;:]=KG M5J/3J+?)5?.:U'^O_7+5_%@GM=N;FT:[W;AM/HO'PBYX_(VJ/D2!6OA'Y#I7 MRY&"=5RJS/"5&G039$X#8IU&+43FR9.0F;.@VS0XSR(M+=COYV>_H99.)I,8 MB44+9K\6JC[ MVD1)TR[Z/(^L7+XAYD40LQ,=!RO4JC<[I%6_NVUU]F]S[CZWVI^O@*'.+0$; MV0%#2.PBN6T1^_C /=P_@[7.DG9[['MOJIU"#3;E6)I.9^OMK+7X.B0 MG6AER4%R7;]J?0*V.Z3^9;+P]>O#YT#B9*]BPPDB%47 M" S@\;Y+1R-&(83-7-[04:0;E2."S\T;DSD2.9TRH(BI@ M#F9 +N$^X5H1IP]9#).S]NP-U$M _1S!8!V'=CU&'.9Y& F9RJ:5,=A_+KFK%;%:M),-#QF3TQYU.'(NE M]YCS:W>F]8%)S1WJQ=*-)KRP9TRGL 6=A.?%C\P2A/_%O,ND2T#O6;8K&?V* M-4Y(^ZOT00!"-A:<;99N>ER20A.9@E/5 (G,S 4P 1RF0^!9[5T1 $?6"BR, MD(&(S%);@Z^JB=#7?01?.#2Z'E3&"28 MG^O_(C)\J(4 M*W869FV5"X4-Q/@2VE[>D;(_U>_O).,^,/:!"$F$[C-)_@PE5RYW4/A;!27V M"S '<0A/V[+#R+?N1RWVNTPU,1API;Z%54'+1R*E_053*GXSR>(].VM/8-=+E8L MTJR3D_*Y"A?$X*?'[Q=#2O?!:82PDFTM&=-K4O@]9&F;2:\&/V]E1SSZ6\NN MQ=R!\-W9F1^MRY#CD8TWN95W>,S ;&[O.MB&T\.6C\)L!%W?>$_-=JO%$^R)^72Z6:;"Z\/ MGDEMZZ=WY8)]>J; &WLLP"D3W\SY",,P+\1" X%$CQH(?0,(:@I-KH+ S,. MGFWODCSX -8+8NBHAB:-,8-+&BLG[V'9S+]G$/:@<20>59I(!M&M?BNDO

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end